DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Beaver JA, Park BH.
The BOLERO-2 trial: the addition of everolimus to exemestane in the treatment of
postmenopausal hormone receptor-positive advanced breast cancer.
Future Oncol 2012;
8: 651-657
Access:
We do not assume any responsibility for the contents of the web pages of other providers.